EUVIMEDEUVIMED entdecken
Crossref

Developing Hypoxia‐Sensitive System via Designing Tumor‐Targeted Fullerene‐Based Photosensitizer for Multimodal Therapy of Deep Tumor

Lei Li, Jiaju Fu, Jiahao Ye, Lei Liu, Zihao Sun, Haoyu Wang, Shuangjie Tan, Mingming Zhen, Chunru Wang iD, Chunli Bai

Advanced Materials · 2024-06 · 36 (23)

DOI: 10.1002/adma.202310875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 13.03.2024. Verfasst von Lei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for E…. Hauptthemen laut MEDLINE: Fullerenes, Photosensitizing Agents, Photochemotherapy, Tirapazamine. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: key deployment project of the Chinese Academy of Sciences, National Natural Science Foundation of China, Youth Innovation Promotion Association of CAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) has been approved for clinic. However, powerless efficiency for deep hypoxic tumor therapy remains an enormous challenge for PDT. Herein, a hypoxia‐sensitive nanotherapeutic system (FTCD‐SRGD) based on fullerene (C 70 ) and anoxic activating chemical prodrug tirapazamine (TPZ) is rationally designed for multimodal therapy of deep hypoxic tumors. To enhance the accumulation and achieve specific drug release in tumor, the FTCD‐SRGD is modified with cyclo(Arg‐Gly‐Asp‐d‐Phe‐Lys) (cRGDfK) peptide and disulfide bonds. With the exacerbated hypoxic microenvironment created by C 70 consuming O 2 for generating reactive oxygen species (ROS), TPZ is activated to produce toxic radical species to ablate deep tumors, which achieves a synergistic treatment of C 70 ‐mediated PDT and hypoxia‐enhanced chemotherapy. Additionally, given this hypoxia‐sensitive system‐induced immunogenic cell death (ICD) activating anticancer cytotoxic T lymphocyte to result in more susceptible tumor to immunotherapy, FTCD‐SRGD plus immune checkpoint inhibitor (anti‐PD‐L1) fully inhibit deep hypoxic tumors by promoting infiltration of effector T cells in tumors. Collectively, it is the first time to develop a multimodal therapy system with fullerene‐based hypoxia‐sensitive PS for deep tumors. The powerful multimodal nanotherapeutic system for combining hypoxia‐enhanced PDT and immunotherapy to massacre deep hypoxic tumors can provide a paradigm to combat the present bottleneck of tumor therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FullerenesPhotosensitizing AgentsPhotochemotherapyTirapazamineAnimalsMiceCell Line, TumorHumansCombined Modality TherapyTumor MicroenvironmentReactive Oxygen SpeciesNeoplasmsTumor HypoxiaProdrugsAntineoplastic Agents

Stichwörter der Autor:innen

deep hypoxic tumorfullerenehypoxiamultimodal therapyreactive oxygen species

Substanzen

FullerenesPhotosensitizing AgentsTirapazamineReactive Oxygen SpeciesProdrugsAntineoplastic Agents

Autor:innen und Institutionen

  • Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Acade…
  • University of Chinese Academy of Sciences, Beijing, 100049, China.

ORCID-Profile: Chunru Wang

Förderung

  • key deployment project of the Chinese Academy of Sciences
  • National Natural Science Foundation of China
  • Youth Innovation Promotion Association of CAS

Zitieren

APA

Li, L., Fu, J., Ye, J., Liu, L., Sun, Z., Wang, H., Tan, S., Zhen, M., Wang, C., & Bai, C. (2024). Developing Hypoxia‐Sensitive System via Designing Tumor‐Targeted Fullerene‐Based Photosensitizer for Multimodal Therapy of Deep Tumor. Advanced Materials, 36(23). https://doi.org/10.1002/adma.202310875

Vancouver

Li L, Fu J, Ye J, Liu L, Sun Z, Wang H, et al. Developing Hypoxia‐Sensitive System via Designing Tumor‐Targeted Fullerene‐Based Photosensitizer for Multimodal Therapy of Deep Tumor. Advanced Materials. 2024;36(23). doi:10.1002/adma.202310875

BibTeX
@article{Li2024,
  author = {Li, Lei and Fu, Jiaju and Ye, Jiahao and Liu, Lei and Sun, Zihao and Wang, Haoyu and Tan, Shuangjie and Zhen, Mingming and Wang, Chunru and Bai, Chunli},
  title = {Developing Hypoxia‐Sensitive System via Designing Tumor‐Targeted Fullerene‐Based Photosensitizer for Multimodal Therapy of Deep Tumor},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {23},
  doi = {10.1002/adma.202310875}
}
Kostenlos starten →